Skip to content

Ticagrelor

Ticagrelor, sold as Brilinta, is the only product on this shelf: a 90 mg tablet that reduces the risk of heart attack and stroke after Acute Coronary Syndrome.

Brilinta

Acute Coronary Syndrome, Myocardial Infarction

90mg

Ticagrelor tablets for acute coronary syndrome and heart attack. It stops platelets from sticking together by blocking the signals that activate them.

From$3.11/ tabletView

Key points

  • Antiplatelet medicine: ticagrelor stops platelets from collecting and forming clots that may trigger a cardiac event.
  • Carries a boxed warning for serious or life-threatening bleeding; you will bruise and bleed more easily while taking it.
  • Stopping ticagrelor without medical guidance raises the risk of heart attack or stroke.

How does Ticagrelor work?

Ticagrelor blocks a receptor on platelets called P2Y12, the signal that tells them to stick together and form a clot. Without that signal, platelets stay separate and blood flows more freely through narrowed arteries. It sits in the Blood Thinners category.

Further reading